HP INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) | |||||||
Three months ended | |||||||
July 31, 2024 | July 31, 2023 | ||||||
Cash flows from operating activities: | |||||||
Net earnings | $ | 640 | $ | 766 | |||
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||||
Depreciation and amortization | 208 | 217 | |||||
Stock-based compensation expense | 96 | 91 | |||||
Restructuring and other charges | 46 | 75 | |||||
Deferred taxes on earnings | 69 | 51 | |||||
Other, net | (11 | ) | (97 | ) | |||
Changes in operating assets and liabilities, net of acquisitions: | |||||||
Accounts receivable | (341 | ) | (246 | ) | |||
Inventory | (275 | ) | (10 | ) | |||
Accounts payable | 1,082 | 801 | |||||
Net investment in leases from integrated financing | (42 | ) | (31 | ) | |||
Taxes on earnings | 39 | 24 | |||||
Restructuring and other | (60 | ) | (77 | ) | |||
Other assets and liabilities | (27 | ) | (588 | ) | |||
Net cash provided by operating activities | 1,424 | 976 | |||||
Cash flows from investing activities: | |||||||
Investment in property, plant and equipment, net | (162 | ) | (137 | ) | |||
Purchases of available-for-sale securities and other investments | — | (1 | ) | ||||
Collateral (posted) returned for derivative instruments | (60 | ) | 9 | ||||
Payment made in connection with business acquisition, net of cash acquired | (15 | ) | — | ||||
Net cash used in investing activities | (237 | ) | (129 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from short-term borrowings with original maturities less than 90 days, net | — | 200 | |||||
Proceeds from debt, net of issuance costs | 80 | 60 | |||||
Payment of debt and associated costs | (51 | ) | (1,067 | ) | |||
Stock-based award activities and others | 13 | — | |||||
Repurchase of common stock | (600 | ) | — | ||||
Cash dividends paid | (268 | ) | (259 | ) | |||
Settlement of cash flow hedges | — | (3 | ) | ||||
Net cash used in financing activities | (826 | ) | (1,069 | ) | |||
Increase (decrease) in cash, cash equivalents and restricted cash | 361 | (222 | ) | ||||
Cash, cash equivalents and restricted cash at beginning of period | 2,517 | 1,940 | |||||
Cash, cash equivalents and restricted cash at end of period | $ | 2,878 | $ | 1,718 |